ANUPRIYA SINGH: Open Payments
NPI 1952925653 · GAINESVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$531 in 23 payments from 11 companies in 2025. Trend: 2023 $2,230 · 2024 $1,180 · 2025 $531
Food & beverage: $531
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 7 | $152 |
| Medtronic, Inc. | 3 | $102 |
| Averitas Pharma Inc. | 3 | $94 |
| ABBVIE INC. | 3 | $49 |
| Saluda Medical Americas, Inc. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Valinor Pharma, LLC | 1 | $19 |
| Boston Scientific Corporation | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| PFIZER INC. | 1 | $16 |
Products named: Belbuca, QUTENZA, INCEPTIV, SYNCHROMEDII, UBRELVY, XTAMPZA, Evoke, Symbravo.
Industry payments across FL — which companies pay providers there.
